Home > Boards > US Listed > Biotechs >

Genocea Biosciences, Inc (GNCA)

GNCA RSS Feed
Add GNCA Price Alert      Hide Sticky   Hide Intro
Moderator: NY1972
Search This Board: 
Last Post: 3/6/2021 10:08:50 PM - Followers: 34 - Board type: Free - Posts Today: 0

GNCA
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GNCA News: Statement of Changes in Beneficial Ownership (4) 03/02/2021 09:11:33 AM
GNCA News: Securities Registration: Employee Benefit Plan (s-8) 02/22/2021 04:40:41 PM
GNCA News: Annual Report (10-k) 02/22/2021 04:37:43 PM
GNCA News: Statement of Changes in Beneficial Ownership (4) 02/18/2021 11:26:22 AM
GNCA News: Amended Statement of Ownership (sc 13g/a) 02/16/2021 04:40:00 PM
PostSubject
#507   Correct URL below. No PD1 or FOX+ depletion NY1972 03/06/21 10:08:50 PM
#506   It would be interesting to test the therapy jondoeuk 03/06/21 08:13:28 PM
#505   Bought 3K inhibigens. NY1972 03/04/21 02:37:03 PM
#504   Massively parallel interrogation and mining of natively paired NY1972 03/02/21 10:38:39 PM
#503   Another company (Instil Bio) https://www.sec.gov/Archives/edgar/data/1789769/000 jondoeuk 03/01/21 07:06:44 PM
#502   Much earlier than I thought http://www.globenewswire.com/fr/news-release/2021/03/01/2184790/0/en/Ach jondoeuk 03/01/21 07:06:10 PM
#501   Treg in human breast cancer may considerably stem NY1972 02/26/21 05:56:59 PM
#500   Another company is doing something similar https://s3.us-east-1.amazonaws.com/re jondoeuk 02/15/21 04:00:41 PM
#499   Patients with high-risk solid tumors reported to express NY1972 02/13/21 09:40:29 PM
#498   No anti PD-1 or lymphodepletion req'd. NY1972 02/13/21 09:16:55 PM
#497   Yes, you were right about the dose, as jondoeuk 02/13/21 08:08:10 PM
#496   I doubt that P1 data is worth much. NY1972 02/05/21 10:22:56 PM
#495   I thought their P1 dose was too low. NY1972 02/05/21 10:03:43 PM
#494   Some data https://www.globenewswire.com/news-release/2020/11/10/2123595/0/en/Imm jondoeuk 02/05/21 02:18:23 PM
#493   An IPO could happen later in the year https://www.globenewswire.com/news-release jondoeuk 02/05/21 02:16:21 PM
#492   Likely MRKR's, but imagine what CRISPR engineered product jondoeuk 02/05/21 02:14:47 PM
#491   Compared to ACTolog® (IMA101) is a personalized multi-target NY1972 02/04/21 10:50:12 PM
#490   We expanded polyclonal T cells reactive to five NY1972 02/04/21 10:36:05 PM
#489   patients with chemorefractory lymphomas, two (of seven) with NY1972 02/04/21 06:11:42 PM
#488   Biospace NY1972 02/02/21 06:26:01 PM
#487   Cancer is playing tug of war. GNCA 011 NY1972 02/02/21 06:00:46 PM
#486   NeoVax is (very) similar to what Neon Therapeutics jondoeuk 02/02/21 04:23:07 PM
#485   I think GNCA should be exploring different cytokines jondoeuk 02/02/21 04:19:11 PM
#484   New publication in Cancer Discovery highlighting the advantages jondoeuk 02/02/21 04:16:22 PM
#483   GEN-011 DP = TIL precursors NY1972 01/28/21 12:18:40 PM
#482   immune responses of eight patients with surgically resected NY1972 01/28/21 11:58:07 AM
#481   Anti-PDL1 works in TDLN not TME. NY1972 01/27/21 04:56:39 PM
#480   FT596 targets CD19 and is combined with an jondoeuk 01/27/21 02:29:57 PM
#479   Targeting PD(L)-1* has some effects in certain chronic jondoeuk 01/27/21 02:22:25 PM
#478   I guess FATE FT596 works in pts w/ NY1972 01/25/21 09:38:42 PM
#477   Pharmas are nuts. GILD paid 6B for 47. NY1972 01/25/21 09:14:41 PM
#476   From Dr. DeSantis https://twitter.com/DrPaulyDeSantis/status/1347266439728689153 jondoeuk 01/24/21 09:32:26 PM
#475   FATE The open-label, multi-center phase I study is designed NY1972 01/24/21 08:40:34 PM
#474   Early-relapse tumors have reduced levels of regulatory T NY1972 01/24/21 08:15:02 PM
#473   MEK inhibition reprograms CD8+ T lymphocytes into memory NY1972 01/23/21 09:49:17 PM
#472   Low-dose decitabine priming endows CAR T cells NY1972 01/23/21 09:43:47 PM
#471   PD1 role in acute infection is not than NY1972 01/23/21 02:15:47 PM
#470   With PD-1 KO they should be able to jondoeuk 01/22/21 08:28:29 PM
#469   True, but when compared to others who are jondoeuk 01/22/21 08:17:41 PM
#468   EGFR–mutant is the most well known inhibigen? NY1972 01/20/21 09:20:52 PM
#466   we also investigated the contribution of T cell-expressed NY1972 01/20/21 02:11:55 PM
#465   Avadomide + TIL? NY1972 01/20/21 12:37:37 PM
#464   ATLAS is a better tool than EDGE. NY1972 01/19/21 08:25:05 PM
#463   What IOVA found: NY1972 01/16/21 09:39:05 PM
#462   IOVA needs to test their TIL without lymphodepletion NY1972 01/16/21 09:11:11 PM
#461   I have studied the posted, but the ORR jondoeuk 01/15/21 04:03:26 PM
#460   TIL not so effective. ORR = 33% at NY1972 01/15/21 12:39:50 PM
#459   Does It Make Sense to Add Immune Checkpoint NY1972 01/13/21 09:13:12 PM
#458   I agree. Adding certain small molecules could be jondoeuk 01/13/21 07:02:14 PM
#457   Day two https://nci.rev.vbrick.com/#/videos/7bf4d3df-bbf8-4712-8f29-fd7c51d0eb93 jondoeuk 01/13/21 06:57:24 PM
PostSubject
Consent Preferences